News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


“Thrilled & Relieved” Vital Drug May Be Funded

Years of lobbying appear to have paid off in the fight for funding of a revolutionary drug to treat cystic fibrosis.

Pharmac has today announced it’s reached a provisional agreement with drug company Vertex to fund ivacaftor, better known as Kalydeco. If feedback from a consultation process with health professionals is supportive and the proposal approved, patients could get access to the drug from as early as March 1st.

“This is a monumental day for the CF community and marks the culmination of many years of lobbying for access to innovative medicines,” says Cystic Fibrosis NZ Chief Executive Jane Bollard.
“I want to thank everyone who has been a part of this campaign for their persistence and determination to keep on fighting” says Bollard. “A special thanks to Eddie and Emma Porter of the ‘Kalydeco for Kiwis’ advocacy group for their work on the campaign”.
The Porters are parents to Otis, aged two and a half, who was born with the inherited, life-threatening lung disorder that effects the lungs and digestive system. The couple established the ‘Kalydeco for Kiwis’ campaign in 2018, a year after Otis’ birth, culminating in the delivery of an 11,000-strong petition to parliament last November calling for the drug to be funded immediately. Pharmac agreed in principal to fund Kalydeco last February, but only as a low priority, meaning the chances of it ever being funded were slim and unclear. This agreement now gives patients far more certainty.

“This is so exciting for the future of not only our own little boy but dozens of other CF patients in New Zealand with the G551D mutation who are in desperate need of Kalydeco” says Eddie Porter. “This will completely change Otis’ future and give him a life expectancy well beyond the current CF average of 37 years. He now realistically faces less sickness and hospitalisation from debilitating lung infections in the future and the chance of living a far more normal life, like other Kiwi boys his age”.

.Around 530 New Zealanders live with CF. If given the final green light, Kalydeco will treat an estimated 30 New Zealand adults and children living with the G551D mutation of the disease.

Hailed as a ‘miracle drug’, Kalydeco is the first medication to fix the underlying cystic fibrosis defect, as opposed to current medicines which only treat the symptoms. It drastically improves life expectancy and reduces life-threatening symptoms. Until now, New Zealand has been the only OECD country to NOT fund Kalydeco, with many patients considering a shift to Australia to gain access to it.

“While we are hugely excited Kalydeco has been funded, we look forward to this being the first of many more modern drugs Pharmac considers funding to treat many more of the 530 New Zealanders living with the disease, such as Orkambi, Symdeko and Trikafta” says Jane Bollard. “The fight for these patients continues”.

© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Howard Davis: Charlotte Yates' Mansfield Project

Katherine Mansfield's vapid verses are of even less interest than her over-rated short stories, but Yates has risen to the challenge of producing a fascinating compilation album by a variety of musicians to accompany her poetry. More>>

Howard Davis: Dazed & Confused by Beats

Beats is both a coming-of-age tale and a romantic movie about endings, set to a nostalgic backdrop of the disappearing tail of the UK's illegal rave scene. More>>

Howard Davis: And The Oscar Goes To … Parasite

For its deliciously dark wit and genre-bending ingenuity, Bong Joon-ho's latest movie has just won four out of a potential six Academy Awards, including Best Screenplay and Director. Only ten foreign-language films have previously been nominated for Best Picture and none have won before. More>>

Howard Davis: 1917's 1,000 Yard Stare

Sam Mendes has created a terrible and barbarous trek, one that we appreciate all the more for being catapulted right into the midst of this ear-splitting melee from the film's opening sequence. More>>




  • Wellington
  • Christchurch
  • Auckland